Report cover image

Global Human Organoids Market Size Study, by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), by Disease Area (Oncology, GI, Neurological Disorders), and Regional Forecasts 2024-2034

Publisher Factview Research
Published Jun 27, 2025
Length 285 Pages
SKU # FAVR20179335

Description

The global human organoids market, valued at approximately USD 1.09 billion in 2024, is anticipated to grow at a (CAGR) of 14.80% during the forecast period 2024-2034. Human organoids represent a groundbreaking advancement in biotechnology, enabling the replication of miniature, functional versions of organs in vitro. These sophisticated 2D and 3D models are pivotal for drug discovery, toxicity studies, and personalized medicine, allowing researchers to simulate human physiological processes with unprecedented accuracy. Leveraging technologies like organ-specific differentiation protocols and advanced scaffolding, organoids are driving a paradigm shift in disease modeling and regenerative medicine.

The escalating prevalence of complex diseases such as cancer, neurological disorders, and gastrointestinal conditions underscores the critical demand for advanced preclinical models. Human organoids, offering insights into cellular and molecular dynamics, are emerging as indispensable tools for pharmaceutical and biotech companies. Notably, advancements in organoid-derived platforms for liver, kidney, and pancreatic models have accelerated their adoption in drug toxicity testing, revolutionizing the preclinical evaluation process. Meanwhile, personalized medicine is gaining traction, where patient-specific organoids are employed to predict individual responses to treatments, paving the way for targeted therapeutic strategies.

Despite the immense promise, the market grapples with challenges including high costs of development and scalability issues. Additionally, the complexity of organoid creation and limited standardization of protocols across labs pose significant hurdles. However, collaborative efforts among key stakeholders—spanning academic institutions, biotechnology firms, and contract research organizations (CROs)—are fostering innovation to address these barriers. The integration of artificial intelligence (AI) with organoid research is further driving optimization in predictive modeling and high-throughput screening.

Regionally, North America commands a dominant market share, buoyed by cutting-edge research infrastructure, substantial investments in biotechnology, and strong industry-academic partnerships. Europe follows suit, benefiting from supportive regulatory frameworks and government initiatives promoting precision medicine. Meanwhile, the Asia-Pacific region is poised to witness the fastest growth, driven by increasing healthcare R&D expenditure and rising adoption of innovative technologies in emerging economies like China and India. Latin America and the Middle East & Africa also present lucrative opportunities, as growing awareness about organoid technologies catalyzes regional adoption.

Major market players included in this report are:
  • Thermo Fisher Scientific
  • STEMCELL Technologies
  • Organoid Therapeutics
  • Cellesce Ltd.
  • Hubrecht Organoid Technology
  • Corning Incorporated
  • QGel SA
  • Lonza Group AG
  • Merck KGaA
  • BioIVT
  • Axosim, Inc.
  • TissUse GmbH
  • DefiniGEN
  • CN Bio Innovations
  • 3D Biotek, LLC
The detailed segments and sub-segments of the market are explained below:

By Product:
  • Liver Models
2D

3D
  • Kidney Models
2D

3D
  • Pancreatic Models
2D

3D

By Disease Area:
  • Oncology
  • Gastrointestinal (GI) Disorders
  • Neurological Disorders
By Application:
  • Drug Toxicity Testing
  • Personalized Medicine
By End User:
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
By Region: North America:
  • U.S.
  • Canada
Europe:
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia Pacific:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
Latin America:
  • Brazil
  • Mexico
  • Rest of Latin America
Middle East & Africa:
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
Years considered for the study are as follows:
  • Historical Year – 2022
  • Base Year – 2024
  • Forecast Period – 2024 to 2034
Key Takeaways:
  • Detailed market estimates and forecasts from 2022 to 2032.
  • Comprehensive regional analysis, including country-level insights.
  • Thorough segmentation covering type, therapy, population type, drug type, route of administration, end user, and distribution channels.
  • Competitive landscape profiling leading market players and their strategies.
  • Actionable insights for stakeholders to capitalize on emerging trends and growth opportunities.

Table of Contents

285 Pages
Chapter 1. Global Human Organoids Market Executive Summary
1.1. Global Human Organoids Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Disease Area
1.3.3. By Application
1.3.4. By End User
1.4. Key Trends
1.6. Investment Analysis
1.7. Investment Rationale
1.8. Analyst Recommendation & Conclusion
Chapter 2. Global Human Organoids Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Human Organoids Market Dynamics
3.1. Market Drivers
3.1.1. Growing Demand for Advanced Preclinical Models
3.1.2. Increasing Investments in Biotechnology R&D
3.1.3. Advancements in Organoid Technology
3.2. Market Challenges
3.2.1. High Development Costs
3.2.2. Scalability and Standardization Issues
3.3. Market Opportunities
3.3.1. Collaborative Innovations and Cost-effective Solutions
3.3.2. Integration of AI in Organoid Research
3.3.3. Expansion in Emerging Markets
Chapter 4. Global Human Organoids Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Human Organoids Market Size & Forecasts by Product 2024-2034
5.1. Segment Dashboard
5.2. Global Human Organoids Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Liver Models
5.2.1.1. 2D
5.2.1.2. 3D
5.2.2. Kidney Models
5.2.2.1. 2D
5.2.2.2. 3D
5.2.3. Pancreatic Models
5.2.3.1. 2D
5.2.3.2. 3D
Chapter 6. Global Human Organoids Market Size & Forecasts by Disease Area 2024-2034
6.1. Segment Dashboard
6.2. Global Human Organoids Market: Disease Area Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Oncology
6.2.2. Gastrointestinal (GI) Disorders
6.2.3. Neurological Disorders
Chapter 7. Global Human Organoids Market Size & Forecasts by Application 2024-2034
7.1. Segment Dashboard
7.2. Global Human Organoids Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. Drug Toxicity Testing
7.2.2. Personalized Medicine
Chapter 8. Global Human Organoids Market Size & Forecasts by End User 2024-2034
8.1. Segment Dashboard
8.2. Global Human Organoids Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Contract Research Organizations (CROs)
Chapter 9. Global Human Organoids Market Size & Forecasts by Region 2024-2034
9.1. North America Human Organoids Market
9.1.1. U.S. Human Organoids Market
9.1.1.1. Product Breakdown Size & Forecasts, 2024-2034
9.1.1.2. Disease Area Breakdown Size & Forecasts, 2024-2034
9.1.1.3. Application Breakdown Size & Forecasts, 2024-2034
9.1.1.4. End User Breakdown Size & Forecasts, 2024-2034
9.1.2. Canada Human Organoids Market
9.1.2.1. Product Breakdown Size & Forecasts, 2024-2034
9.1.2.2. Disease Area Breakdown Size & Forecasts, 2024-2034
9.1.2.3. Application Breakdown Size & Forecasts, 2024-2034
9.1.2.4. End User Breakdown Size & Forecasts, 2024-2034
9.2. Europe Human Organoids Market
9.2.1. UK Human Organoids Market
9.2.2. Germany Human Organoids Market
9.2.3. France Human Organoids Market
9.2.4. Spain Human Organoids Market
9.2.5. Italy Human Organoids Market
9.2.6. Rest of Europe Human Organoids Market
9.3. Asia-Pacific Human Organoids Market
9.3.1. China Human Organoids Market
9.3.2. India Human Organoids Market
9.3.3. Japan Human Organoids Market
9.3.4. Australia Human Organoids Market
9.3.5. South Korea Human Organoids Market
9.3.6. Rest of Asia Pacific Human Organoids Market
9.4. Latin America Human Organoids Market
9.4.1. Brazil Human Organoids Market
9.4.2. Mexico Human Organoids Market
9.4.3. Rest of Latin America Human Organoids Market
9.5. Middle East & Africa Human Organoids Market
9.5.1. Saudi Arabia Human Organoids Market
9.5.2. South Africa Human Organoids Market
9.5.3. Rest of Middle East & Africa Human Organoids Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Thermo Fisher Scientific
10.1.2. STEMCELL Technologies
10.1.3. Organoid Therapeutics
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Thermo Fisher Scientific
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. STEMCELL Technologies
10.3.3. Organoid Therapeutics
10.3.4. Cellesce Ltd.
10.3.5. Hubrecht Organoid Technology
10.3.6. Corning Incorporated
10.3.7. QGel SA
10.3.8. Lonza Group AG
10.3.9. Merck KGaA
10.3.10. BioIVT
10.3.11. Axosim, Inc.
10.3.12. TissUse GmbH
10.3.13. DefiniGEN
10.3.14. CN Bio Innovations
10.3.15. 3D Biotek, LLC
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us